IL75963A0 - Interferon derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Interferon derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL75963A0
IL75963A0 IL75963A IL7596385A IL75963A0 IL 75963 A0 IL75963 A0 IL 75963A0 IL 75963 A IL75963 A IL 75963A IL 7596385 A IL7596385 A IL 7596385A IL 75963 A0 IL75963 A0 IL 75963A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
interferon derivatives
interferon
Prior art date
Application number
IL75963A
Other versions
IL75963A (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/en
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL75963A0 publication Critical patent/IL75963A0/en
Publication of IL75963A publication Critical patent/IL75963A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The type I interferon peptides encoded by the genetic DNA sequences are called omega-interferons and are produced using appropriate expression vehicles and organisms.
IL75963A 1984-08-01 1985-07-30 Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them IL75963A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3428370A DE3428370A1 (en) 1984-08-01 1984-08-01 Interferon, genetic sequences which code therefor, and organisms producing these
DE19853505060 DE3505060A1 (en) 1985-02-14 1985-02-14 Type I interferons, genetic sequences which code therefor, and organisms producing these

Publications (2)

Publication Number Publication Date
IL75963A0 true IL75963A0 (en) 1985-12-31
IL75963A IL75963A (en) 1992-05-25

Family

ID=25823496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75963A IL75963A (en) 1984-08-01 1985-07-30 Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0170204B1 (en)
JP (2) JP2566909B2 (en)
KR (1) KR0136799B1 (en)
AT (1) ATE67786T1 (en)
AU (1) AU600653B2 (en)
BG (1) BG60445B2 (en)
CA (1) CA1340184C (en)
DD (1) DD246318A5 (en)
DE (1) DE3584198D1 (en)
DK (1) DK175194B1 (en)
ES (2) ES8609475A1 (en)
FI (1) FI90667C (en)
GR (1) GR851866B (en)
HK (1) HK187896A (en)
HU (1) HU205779B (en)
IE (1) IE58942B1 (en)
IL (1) IL75963A (en)
MX (1) MX9203645A (en)
NO (1) NO177863C (en)
NZ (1) NZ212937A (en)
PT (1) PT80901B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
EP0490233A1 (en) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonal antibodies against Bgl III-hybrid interferons, their use and process for preparing them
DE3607835A1 (en) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int HYBRID INTERFERONS, THEIR USE AS MEDICINAL PRODUCTS AND AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF ANTIBODIES AND THE USE THEREOF AND METHOD FOR THEIR PRODUCTION
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (en) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int NEW MONOCLONAL ANTIBODIES AGAINST IFN-OMEGA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CLEANING AND DETECTING IFN-OMEGA
DE3635867A1 (en) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int NEW YEAR EXPRESSION VECTORS FOR IFN-OMEGA, METHOD FOR THEIR PRODUCTION AND USE THEREOF
WO1999026663A2 (en) * 1997-11-20 1999-06-03 Vical, Inc. Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
CA2818688A1 (en) * 2002-03-07 2003-09-12 Eidgenossische Technische Hochschule Zurich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
EP1481057B1 (en) 2002-03-07 2006-02-15 Eidgenössische Technische Hochschule Zürich System and method for the production of recombinant glycosylated proteins in a prokaryotic host
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
WO2004096852A1 (en) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla A RECOMBINANT HUMAN INTERFERON ϖ, THE METHOD FOR EXPRESSING IT AND THE USES OF IT
ES2703061T3 (en) 2005-05-11 2019-03-06 Eth Zuerich N-glycosylated recombinant proteins from prokaryotic cells
EP3427749A1 (en) 2008-02-20 2019-01-16 GlaxoSmithKline Biologicals SA Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
NO2501406T3 (en) 2009-11-19 2018-05-19
SI2566507T1 (en) 2010-05-06 2018-04-30 Glaxosmithkline Biologicals Sa Capsular gram-positive bacteria bioconjugate vaccines
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
DE3247922A1 (en) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS
ATE47864T1 (en) * 1984-08-27 1989-11-15 Genentech Inc MISCELLANEOUS FAMILY OF HUMAN WBC INTERFERONS, COMPOSITIONS CONTAINING THEM, METHODS FOR THEIR PRODUCTION, AND DNA AND TRANSFECTED HOSTS THEREOF.

Also Published As

Publication number Publication date
ES552431A0 (en) 1987-09-01
IE58942B1 (en) 1993-12-01
PT80901A (en) 1985-09-01
NO177863C (en) 1995-12-06
IE851906L (en) 1986-02-01
KR870001310A (en) 1987-03-13
AU4554985A (en) 1986-02-06
FI90667C (en) 1994-03-10
MX9203645A (en) 1992-09-01
HU205779B (en) 1992-06-29
ES8609475A1 (en) 1986-08-01
EP0170204A2 (en) 1986-02-05
BG60445B2 (en) 1995-03-31
DK346385D0 (en) 1985-07-30
EP0170204B1 (en) 1991-09-25
FI852956A0 (en) 1985-07-31
HUT39477A (en) 1986-09-29
HK187896A (en) 1996-10-18
DK175194B1 (en) 2004-07-05
EP0170204A3 (en) 1988-02-17
JP2566909B2 (en) 1996-12-25
ES8708013A1 (en) 1987-09-01
FI852956L (en) 1986-02-02
PT80901B (en) 1989-01-17
GR851866B (en) 1985-12-02
DK346385A (en) 1986-02-02
IL75963A (en) 1992-05-25
NO853012L (en) 1986-02-03
JP2567195B2 (en) 1996-12-25
JPH06181771A (en) 1994-07-05
JPS61181381A (en) 1986-08-14
NZ212937A (en) 1991-08-27
CA1340184C (en) 1998-12-15
FI90667B (en) 1993-11-30
NO177863B (en) 1995-08-28
AU600653B2 (en) 1990-08-23
ES545725A0 (en) 1986-08-01
DE3584198D1 (en) 1991-10-31
ATE67786T1 (en) 1991-10-15
DD246318A5 (en) 1987-06-03
KR0136799B1 (en) 1998-04-25

Similar Documents

Publication Publication Date Title
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
EP0177568A4 (en) Recombinant dna molecules.
AU2608292A (en) Human immunoglobulins produced by recombinant dna techniques
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
IL98134A0 (en) Single chain t-receptors,nucleic acid sequences coding therefor and pharmaceutical compositions containing the same
DK1396542T3 (en) P-selectin ligand protein
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
ATE175237T1 (en) POLYPEPTIDES INVOLVED IN COBALAMINE AND/OR COBAMIDE BIOSYNTHESIS, FOR THESE DNA SEQUENCES CODING, AND THEIR PRODUCTION AND USE.
IT8119759A0 (en) HUMAN, DNA AND PLASMIDS WHICH PRODUCT POLYPEPTIDE CODE FOR THIS SEQUENCE, MICROBIOLOGICALLY WITH THE SEQUENCE MICROORGANISMS THAT CONTAIN INTERFERON AMINO ACIDS THIS GENETIC INFORMATION AND PROCESS FOR THEIR PREPARATION.
DE3574145D1 (en) Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor
DE3783145T2 (en) RECOMBINANT DNA PLASMIDE FOR THE PRODUCTION OF XANTHAN GUM.
IL79797A (en) Expression dna sequence for use in e.coli
WO1990003394A3 (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same
AU638682C (en) New limphokines, DNA sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
CA2143442A1 (en) Dorsal tissue affecting factor and compositions
IE891572L (en) Polypeptide expressible by dna sequence
MX9708877A (en) 'delta'p62, variants thereof, nucleic acid sequences and uses thereof.

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
EXP Patent expired